Archives for July 1, 2004

← 2004

Cell-based Parkinson's therapy gets charity boost

A research team based in Sweden is benefiting from a medical charity grant of $3 million (€2.5m) that will help it develop a new cell-based therapy for Parkinson's. Current therapies can only ameliorate the symptoms of the disease.

New automated pipettor from Tomtec

Tomtec has launched a new multipurpose pipetting workstation that can handle tiny volumes (down to less than 1 microlitre) and has features that allows the automation of a number of routine laboratory liquid handling tasks.

Qiagen sells off nucleic acid unit

Qiagen has sold off its embattled nucleic acid synthesis business in a management buyout, but has retained a minority stake and all activities relating to RNA interference (RNAi), a potent new drug discovery tool.

Charles River to buy Inveresk for $1.5bn

Charles River Laboratories has made a $1.5 billion (€1.2bn) bid to acquire Inveresk Research in a deal that will create a contract research powerhouse with nearly $1 billion in annual revenues, writes Phil Taylor.